Andrew Oliveira

Dr. Andrew Oliveira

University of São Paulo

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2023 in ACS Bio & Med Chem Au
Verified
Journal Article
Open access
LMLarissa Maciel
Larissa Maciel
MFMatheus V. F. Ferraz
Matheus V. F. Ferraz
AOAndrew Oliveira
Andrew Oliveira
RLRoberto Lins
Roberto Lins
JAJanaína V. dos Anjos
Janaína V. dos Anjos
TSThereza Soares
Thereza Soares

11 February 2020 in Drug Development Research
Verified
Journal Article
Closed access
PDF file
MGMariana L. Garcia
Mariana L. Garcia
AOAndrew Oliveira
Andrew Oliveira
RBRenata Bueno
Renata Bueno
VNVictor Nogueira
Victor Nogueira
Guilherme SouzaGuilherme Souza
Guilherme Souza
RGRafael Victorio Carvalho Guido
Rafael Victorio Carvalho Guido

11 November 2021 in Molecules
Verified
Journal Article
Open access
PDF file
BMBruna Mazzeu
Bruna Mazzeu
TSTatiana Souza-Moreira
Tatiana Souza-Moreira
AOAndrew Oliveira
Andrew Oliveira
MRMelissa Remlinger
Melissa Remlinger
LFLidiane G. Felippe
Lidiane G. Felippe
MFMaysa Furlan
Maysa Furlan
Friedelin, a pentacyclic triterpene found in the leaves of the Celastraceae species, demonstrates numerous biological activities and is a precursor of quinonemethide triterpenes, which are promising antitumoral agents. Friedelin is biosynthesized from the cyclization of 2,3-oxidosqualene, involving a series of rearrangements to form a ketone by deprotonation of the hydroxylated intermediate, without the aid of an oxidoreductase enzyme. Mutagenesis studies among oxidosqualene cyclases (OSCs) have demonstrated the influence of amino acid residues on rearrangements during substrate cyclization: loss of catalytic activity, stabilization, rearrangement control or specificity changing. In the present study, friedelin synthase from Maytenus ilicifolia (Celastraceae) was expressed heterologously in Saccharomyces cerevisiae. Site-directed mutagenesis studies were performed by replacing phenylalanine with tryptophan at position 473 (Phe473Trp), methionine with serine at position 549 (Met549Ser) and leucine with phenylalanine at position 552 (Leu552Phe). Mutation Phe473Trp led to a total loss of function; mutants Met549Ser and Leu552Phe interfered with the enzyme specificity leading to enhanced friedelin production, in addition to α-amyrin and β-amyrin. Hence, these data showed that methionine 549 and leucine 552 are important residues for the function of this synthase.